IPRIPR2023-00722Institution Denied
Mylan Pharmaceuticals Inc. et al.v.Novo Nordisk A/S
IPR challenge of US 8536122.
Type
IPR
Filed
Mar 16, 2023
Instituted
Oct 2, 2023
Decided
Oct 2, 2023
Patent
Application
13412283
Inventor
Jesper Lau et al
Granted
Sep 17, 2013
01
Timeline
3 milestones
2023-03-16Petition filed
2023-10-02Institution
2023-10-02Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Counsel
White, Brandonet al
Patent Owner
Novo Nordisk A/S
Counsel
Baughman, Jonet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →